Synopsis
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Thickeners and Stabilizers
Direct Compression
Lubricants & Glidants
Granulation
Co-Processed Excipients
Disintegrants & Superdisintegrants
Coating Systems & Additives
Solubilizers
Controlled & Modified Release
Rheology Modifiers
Chewable & Orodispersible Aids
Emulsifying Agents
Film Formers & Plasticizers
Taste Masking
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ANALYTICAL
ABOUT THIS PAGE
14
PharmaCompass offers a list of Dapagliflozin Propanediol Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dapagliflozin Propanediol Monohydrate manufacturer or Dapagliflozin Propanediol Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dapagliflozin Propanediol Monohydrate manufacturer or Dapagliflozin Propanediol Monohydrate supplier.
A dapagliflozin (S)-propylene glycol hydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of dapagliflozin (S)-propylene glycol hydrate, including repackagers and relabelers. The FDA regulates dapagliflozin (S)-propylene glycol hydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. dapagliflozin (S)-propylene glycol hydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A dapagliflozin (S)-propylene glycol hydrate supplier is an individual or a company that provides dapagliflozin (S)-propylene glycol hydrate active pharmaceutical ingredient (API) or dapagliflozin (S)-propylene glycol hydrate finished formulations upon request. The dapagliflozin (S)-propylene glycol hydrate suppliers may include dapagliflozin (S)-propylene glycol hydrate API manufacturers, exporters, distributors and traders.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A dapagliflozin (S)-propylene glycol hydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of dapagliflozin (S)-propylene glycol hydrate active pharmaceutical ingredient (API) in detail. Different forms of dapagliflozin (S)-propylene glycol hydrate DMFs exist exist since differing nations have different regulations, such as dapagliflozin (S)-propylene glycol hydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A dapagliflozin (S)-propylene glycol hydrate DMF submitted to regulatory agencies in the US is known as a USDMF. dapagliflozin (S)-propylene glycol hydrate USDMF includes data on dapagliflozin (S)-propylene glycol hydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The dapagliflozin (S)-propylene glycol hydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a dapagliflozin (S)-propylene glycol hydrate Drug Master File in Korea (dapagliflozin (S)-propylene glycol hydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of dapagliflozin (S)-propylene glycol hydrate. The MFDS reviews the dapagliflozin (S)-propylene glycol hydrate KDMF as part of the drug registration process and uses the information provided in the dapagliflozin (S)-propylene glycol hydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a dapagliflozin (S)-propylene glycol hydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their dapagliflozin (S)-propylene glycol hydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with KDMF on PharmaCompass.
A dapagliflozin (S)-propylene glycol hydrate CEP of the European Pharmacopoeia monograph is often referred to as a dapagliflozin (S)-propylene glycol hydrate Certificate of Suitability (COS). The purpose of a dapagliflozin (S)-propylene glycol hydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of dapagliflozin (S)-propylene glycol hydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of dapagliflozin (S)-propylene glycol hydrate to their clients by showing that a dapagliflozin (S)-propylene glycol hydrate CEP has been issued for it. The manufacturer submits a dapagliflozin (S)-propylene glycol hydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a dapagliflozin (S)-propylene glycol hydrate CEP holder for the record. Additionally, the data presented in the dapagliflozin (S)-propylene glycol hydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the dapagliflozin (S)-propylene glycol hydrate DMF.
A dapagliflozin (S)-propylene glycol hydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. dapagliflozin (S)-propylene glycol hydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with CEP (COS) on PharmaCompass.
A dapagliflozin (S)-propylene glycol hydrate written confirmation (dapagliflozin (S)-propylene glycol hydrate WC) is an official document issued by a regulatory agency to a dapagliflozin (S)-propylene glycol hydrate manufacturer, verifying that the manufacturing facility of a dapagliflozin (S)-propylene glycol hydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting dapagliflozin (S)-propylene glycol hydrate APIs or dapagliflozin (S)-propylene glycol hydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a dapagliflozin (S)-propylene glycol hydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing dapagliflozin (S)-propylene glycol hydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for dapagliflozin (S)-propylene glycol hydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture dapagliflozin (S)-propylene glycol hydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain dapagliflozin (S)-propylene glycol hydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a dapagliflozin (S)-propylene glycol hydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with NDC on PharmaCompass.
dapagliflozin (S)-propylene glycol hydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of dapagliflozin (S)-propylene glycol hydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right dapagliflozin (S)-propylene glycol hydrate GMP manufacturer or dapagliflozin (S)-propylene glycol hydrate GMP API supplier for your needs.
A dapagliflozin (S)-propylene glycol hydrate CoA (Certificate of Analysis) is a formal document that attests to dapagliflozin (S)-propylene glycol hydrate's compliance with dapagliflozin (S)-propylene glycol hydrate specifications and serves as a tool for batch-level quality control.
dapagliflozin (S)-propylene glycol hydrate CoA mostly includes findings from lab analyses of a specific batch. For each dapagliflozin (S)-propylene glycol hydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
dapagliflozin (S)-propylene glycol hydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (dapagliflozin (S)-propylene glycol hydrate EP), dapagliflozin (S)-propylene glycol hydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (dapagliflozin (S)-propylene glycol hydrate USP).
